OnCore Login

News & Developments

Registration Now Open for 2025 Big Ten Cancer Research Consortium Summit

July 8, 2025:

The Big Ten Cancer Research Consortium is excited to announce registration is now open for the 2025 Big Ten CRC Summit on Friday, September 12, from 7:30 a.m. to 2:15 p.m. CT at the Big Ten Conference Headquarters in Rosemont, Ill. Read More

John Hays, MD, PhD, Named Chair of Big Ten CRC Steering Committee

June 20, 2025: The Big Ten Cancer Research Consortium is pleased to announce John Hays, MD, PhD, as the new chair of the Steering Committee. Dr. Hays is an associate professor in the College of Medicine and member of the Translational Therapeutics Program at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. With a specialty in medical oncology, Dr. Hays brings a commitment to forward thinking and a wealth of experience as a successful leader and mentor.   Read More

Across the Consortium: June 2025

June 11, 2025: 

In this month’s Across the Consortium, the Big Ten Cancer Research Consortium spotlights a wide range of updates from our member institutions. This issue showcases groundbreaking discoveries, acts of philanthropy, and leadership that will shape not only the Big Ten Cancer Research Consortium but also the future of cancer research itself. You’ll also find news of cancer conferences, new research facilities, and impactful research advances.

Read More

Member Feature: The Ohio State University

June 2, 2025:  This month, the Big Ten CRC highlights The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) as our featured member. Asrar Alahmadi, MBBS, serves as an assistant professor in the College of Medicine at The Ohio State University. Dr. Alahmadi is a medical oncologist who specializes in treating thoracic malignancies, including non-small cell lung cancer, small cell lung cancer, thymoma, and mesothelioma. She received her medical degree from King Abdulaziz University in Jeddah, Saudi Arabia, and completed her fellowship in hematology and oncology at Case Western Reserve University in Cleveland, Ohio. Dr. Alahmadi serves as... Read More

Across the Consortium: May 2025

May 22, 2025: In this month’s Across the Consortium, the Big Ten Cancer Research Consortium spotlights a wide range of updates from our member institutions. This issue covers the impact of budget cuts, celebrates distinguished faculty, honors Asian American Pacific Islander Desi Heritage Month, and announces key leadership additions. You’ll also find highlights of media coverage, participation in cancer conferences and forums, recent advances in cancer research and treatment, prevention and recurrence efforts, and the unveiling of new hospital facilities. Read More

Member Feature: Michigan State University

May 13, 2025: This month, the Big Ten Cancer Research Consortium highlights Michigan State University as our featured member. Daniel Isaac, DO, MS, serves as the director of clinical research at Michigan State University Division of Hematology/Oncology. Dr. Isaac joined faculty at Michigan State University in 2019. His research interests are focused on genitourinary malignancies. His current research includes investigations of novel biomarkers in prostate cancer. Dr. Isaac also currently serves on the board of the Michigan Society of Hematology Oncology and has been selected as President-elect. Dr. Isaac earned a Master of Science in Biomechanics and Mechanical Engineering, as well as a Doctor of Osteopathic Medicine from the Edward Via... Read More

Big Ten CRC’s presence at ASCO 2025

May 12, 2025: The Big Ten Cancer Research Consortium (Big Ten CRC) is set to participate in the American Society of Clinical Oncology® (ASCO) 2025 Annual Meeting in Chicago from May 30 to June 3. During the event, two Big Ten CRC studies will be presented, working group meetings will take place, and the Big Ten CRC will host a joint reception with Hoosier Cancer Research Network (HCRN). The Big Ten CRC will also be represented in the exhibit hall at HCRN’s booth, #36117.

Study Presentations

Two Big Ten CRC studies, BTCRC-GI22-588 and BTCRC-LUN16-081, will be presented during ASCO. BTCRC-GI22-588: A phase II study of... Read More

Big Ten CRC Jessen Award supports research on digital intervention for prostate cancer survivors

May 1, 2025:  Right: Roberto Benzo, PhD Left: David Cella, PhD The Big Ten Cancer Research Consortium Foundation announces that Roberto Benzo, PhD, of The Ohio State University, and David Cella, PhD, of Northwestern University, have been awarded the $65,000 Kenneth and Verna Mae Jessen Award for their research proposal, “Development of a Digital Intervention to Promote Cardiovascular Health in Prostate Cancer Survivors: A Cardio-Oncology Approach.” The project was one of 21 proposals submitted for funding consideration through an RFP announced by the Big Ten CRC in late 2024. Proposals were reviewed by a committee of Big Ten CRC leaders and peer investigators, chaired by Kari Wisinski, MD, of the University of... Read More

Across the Consortium: April 2025

April 30, 2025:  In this month’s Across the Consortium, the Big Ten Cancer Research Consortium spotlights advancements in colorectal cancer research, collaborative efforts in prostate cancer studies, recent research grant recipients, new podcast episodes, lung cancer research and prevention initiatives, brain cancer discoveries, leadership transitions, and the critical role of clinical trials. Read More

Member Feature: Indiana University Melvin and Bren Simon Comprehensive Cancer Center

April 7, 2025:   This month, the Big Ten Cancer Research Consortium highlights Indiana University Melvin and Bren Simon Comprehensive Cancer Center (IUSCCC) as our featured member. Misty Dawn Shields, MD, PhD, is an IUSCCC associate member of the Experimental and Developmental Therapeutics research program and assistant professor of clinical medicine. Dr. Shields joined faculty at IUSCCC in August 2022 as a physician scientist with a focus in early phase trials, longitudinal liquid biopsies, and translational studies for novel therapeutics in acquired chemo-resistant small cell lung cancer (SCLC) as principal investigator of the Shields laboratory. Additionally, Dr. Shields serves on the... Read More

University of Illinois

University of Illinois

Indiana University

Indiana University

University of Iowa

University of Iowa

University of Maryland

University of Maryland

University of Michigan

University of Michigan

Michigan State

Michigan State

University of Minnesota

University of Minnesota

University of Nebraska

University of Nebraska

Northwestern University

Northwestern University

Penn State University

Penn State University

Purdue University

Purdue University

Rutgers State University

Rutgers State University

University of Washington

University of Washington

University of Wisconsin

University of Wisconsin

University of Illinois at Chicago

University of Illinois at Chicago

© 2025 All rights reserved.

Big Ten Cancer Research Consortium
7676 Interactive Way, Suite 120, Indianapolis, IN 46278

email: info@bigtencrc.org    phone: 317–921–2050